Sanoptis
VC Fund
Pfaffikon, Switzerland
Sanoptis is an innovative European ophthalmology services group, covering the full spectrum of diagnostic and surgical ophthalmic treatments. The group partners with leading ophthalmologists to deliver on the organic and inorganic growth opportunities within the market.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Sanoptis invests in
Stages Sanoptis invests in
Countries Sanoptis invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Investment Focus
Industry
- Health Care 2 (100%)
- Software 1 (50%)
- Social Impact 1 (50%)
- Cloud Computing 1 (50%)
- Machine Learning 1 (50%)
Stage
- Seed 1 (50%)
- Series B 1 (50%)
Country
- Germany 1 (50%)
- Switzerland 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Volker Wendel
Founder & CEO
|
Founder & CEO | Total investments: 3 | Find email | |
|
Carsten Horn
Founder & CDO
|
Founder & CDO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Skleo Health creates digital solutions to make healthcare accessible for everyone, regardless of location or circumstances. | $3.5M / Seed / Jul 10, 2025 | |
|
|
RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to collect, analyze and organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning. RetinAI has proprietarytechnology that provides unforeseen image quality enhancement, as well as automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies and device manufacturers at similar level of performance as a human would produce. | $7.8M / Series B / Oct 16, 2024 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Sanoptis invest in?
Sanoptis invests primarily in Health Care, Software and Social Impact startups, most often at Seed and Series B stage. Most of the 2 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Sanoptis?
Public channels for Sanoptis include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Sanoptis?
The team at Sanoptis includes Volker Wendel (Founder & CEO) and Carsten Horn (Founder & CDO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!